2011
DOI: 10.1093/jjco/hyq254
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In addition, only patients with clear-cell histology were eligible for the study [8]. Although sunitinib has been universally prescribed to patients with mRCC, few studies have examined the efficacy and safety of this agent in daily clinical practice, especially in patients of Asian ethnicity [12][13][14][15]. Here, we assessed the efficacy and safety of sunitinib in Japanese patients with mRCC in general clinical practice.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, only patients with clear-cell histology were eligible for the study [8]. Although sunitinib has been universally prescribed to patients with mRCC, few studies have examined the efficacy and safety of this agent in daily clinical practice, especially in patients of Asian ethnicity [12][13][14][15]. Here, we assessed the efficacy and safety of sunitinib in Japanese patients with mRCC in general clinical practice.…”
Section: Introductionmentioning
confidence: 99%